In a research report issued today, Wedbush analyst Zarak Khurshid reiterated an Outperform rating on shares of OvaScience Inc (NASDAQ:OVAS) with a $46 price …
Wedbush’s healthcare analyst Zarak Khurshid weighed in with a few insights on OvaScience Inc (NASDAQ:OVAS), after the company announced positive analysis of its AUGMENT fertility treatment, …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today the first published analysis …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that the AUGMENTSM fertility …
H.C.
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced that physicians continue to report improvements …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced the appointment of John P. …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced that Ravi Mehrotra, Ph.D.
Rohit Vanjani of Oppenheimer rates stocks in the biotechnology sector and is one of the top 25 analysts rated on TipRanks. Yesterday, Vanjani made …
In a research report issued today, Oppenheimer analyst Rohit Vanjani maintained an Outperform rating on OvaScience Inc (NASDAQ:OVAS) with a price target of …
